• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用决策试验与评价实验室(DEMATEL)方法分析实施公共卫生和社会措施以预防新冠病毒病传播的障碍。

Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method.

作者信息

Maqbool Annayath, Khan Noor Zaman

机构信息

Department of Mechanical Engineering, National Institute of Technology Srinagar, Jammu and Kashmir, 190006, India.

Department of Mechanical Engineering, National Institute of Technology Srinagar, Jammu and Kashmir, 190006, India.

出版信息

Diabetes Metab Syndr. 2020 Sep-Oct;14(5):887-892. doi: 10.1016/j.dsx.2020.06.024. Epub 2020 Jun 14.

DOI:10.1016/j.dsx.2020.06.024
PMID:32563940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293847/
Abstract

BACKGROUND AND AIMS

COVID-19 is a contagious disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Till now there are no vaccines and explicit medicines available for the treatment of COVID-19 disease, therefore the initiatives like public health and social measures are helpful in limiting the quantity of contaminations and saving lives. Keeping this in view, an attempt has been made in the present work to identify the barriers which hinder the implementation of these public health and social measures METHODS: The barriers to implement public health and social measures for preventing transmission of COVID-19 are identified using systematic literature review and these barriers are then categorized using Decision-making trial and evaluation laboratory (DEMATEL) method.

RESULTS

Results reveal that among ten identified barriers, Lack of resources for implementing public health and social measures is found to be the most influential barrier to implement public health and social measures for preventing transmission of COVID-19.

CONCLUSIONS

The successful implementation of public health and social measures depends on the adequate availability of resources which include medical equipment, personnel and financial dealings. The outcome of this research work will benefit and motivate the higher authorities to consider and overcome various challenges to prevent the transmission of COVID-19.

摘要

背景与目的

新型冠状病毒肺炎(COVID-19)是一种由新型冠状病毒即严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染病。目前尚无用于治疗COVID-19疾病的疫苗和特效药物,因此公共卫生和社会措施等举措有助于限制感染数量并挽救生命。鉴于此,本研究试图找出阻碍这些公共卫生和社会措施实施的障碍。方法:通过系统文献综述确定实施预防COVID-19传播的公共卫生和社会措施的障碍,然后使用决策试验与评价实验室(DEMATEL)方法对这些障碍进行分类。

结果

结果显示,在确定的十个障碍中,实施公共卫生和社会措施缺乏资源被发现是实施预防COVID-19传播的公共卫生和社会措施最具影响力的障碍。

结论

公共卫生和社会措施的成功实施取决于资源的充足供应,这些资源包括医疗设备、人员和资金往来。本研究工作的结果将有助于并激励上级部门考虑并克服各种挑战以预防COVID-19的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e2/7293847/f38067745e59/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e2/7293847/f38067745e59/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e2/7293847/f38067745e59/gr1_lrg.jpg

相似文献

1
Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method.运用决策试验与评价实验室(DEMATEL)方法分析实施公共卫生和社会措施以预防新冠病毒病传播的障碍。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):887-892. doi: 10.1016/j.dsx.2020.06.024. Epub 2020 Jun 14.
2
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.支持严重急性呼吸综合征冠状病毒 2 在出现症状前或无症状时传播的证据。
Emerg Infect Dis. 2020 Jul;26(7). doi: 10.3201/eid2607.201595. Epub 2020 Jun 21.
3
Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures.在放宽身体距离措施的背景下对 COVID-19 的接触者追踪策略建模。
JAMA Netw Open. 2020 Aug 3;3(8):e2019217. doi: 10.1001/jamanetworkopen.2020.19217.
4
'We felt we had beaten it': New Zealand's race to eliminate the coronavirus again.“我们感觉已经战胜了它”:新西兰再次展开消除新冠病毒的竞赛。
Nature. 2020 Aug;584(7821):336. doi: 10.1038/d41586-020-02402-5.
5
NewsCAP: Social distancing is critical in reducing the spread of COVID-19, according to recent analyses.新闻快讯:根据最近的分析,保持社交距离对于减少新冠病毒的传播至关重要。
Am J Nurs. 2020 Aug;120(8):15. doi: 10.1097/01.NAJ.0000694524.92148.71.
6
The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan.台湾地区社区医院在抗击新冠疫情战斗中的预防策略。
J Microbiol Immunol Infect. 2020 Jun;53(3):381-383. doi: 10.1016/j.jmii.2020.03.019. Epub 2020 Mar 20.
7
Public Health Measures and the Reproduction Number of SARS-CoV-2.公共卫生措施与新冠病毒的繁殖数
JAMA. 2020 Jun 2;323(21):2186-2187. doi: 10.1001/jama.2020.7878.
8
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Jun 17;16(698):1274.
9
Lack of safeguards in response to restrictive public health measures.应对限制性公共卫生措施时缺乏保障措施。
Lancet. 2020 Oct 31;396(10260):e70. doi: 10.1016/S0140-6736(20)32118-8. Epub 2020 Oct 8.
10
Assessment of Coronavirus Disease 2019 Community Containment Strategies in Shenzhen, China.中国深圳 2019 年冠状病毒病社区防控策略评估。
JAMA Netw Open. 2020 Jun 1;3(6):e2012934. doi: 10.1001/jamanetworkopen.2020.12934.

引用本文的文献

1
Adverse events associated with AstraZeneca COVID-19 vaccine among adults in Greater Kampala, Uganda: a cross-sectional study.乌干达坎帕拉市成年人中与阿斯利康新冠疫苗相关的不良事件:一项横断面研究。
Afr Health Sci. 2024 Jun;24(2):95-105. doi: 10.4314/ahs.v24i2.12.
2
Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study.患者描述的新冠后综合征:一项定性研究。
Healthcare (Basel). 2025 Mar 28;13(7):757. doi: 10.3390/healthcare13070757.
3
Nanoparticles of natural product-derived medicines: Beyond the pandemic.天然产物衍生药物的纳米颗粒:疫情之后

本文引用的文献

1
Positive externalities of an epidemic: The case of the coronavirus (COVID-19) in China.疫情的正外部性:以中国的冠状病毒(COVID-19)为例。
J Med Virol. 2020 Sep;92(9):1376-1379. doi: 10.1002/jmv.25830. Epub 2020 Apr 10.
2
Testing Individuals for Coronavirus Disease 2019 (COVID-19).对个体进行2019冠状病毒病(COVID-19)检测。
JAMA. 2020 May 19;323(19):1981. doi: 10.1001/jama.2020.5388.
3
Strategies for the prevention and management of coronavirus disease 2019.新型冠状病毒肺炎的预防和管理策略。
Heliyon. 2025 Feb 19;11(4):e42739. doi: 10.1016/j.heliyon.2025.e42739. eCollection 2025 Feb 28.
4
Factors associated with adherence to preventive measures against COVID-19, among adult Bahraini residents.与巴林成年居民遵守 COVID-19 预防措施相关的因素。
Sci Rep. 2024 Nov 3;14(1):26537. doi: 10.1038/s41598-024-76843-7.
5
Wastewater-based epidemiology surveillance as an early warning system for SARS-CoV-2 in Indonesia.基于污水的流行病学监测作为印度尼西亚 SARS-CoV-2 的预警系统。
PLoS One. 2024 Jul 18;19(7):e0307364. doi: 10.1371/journal.pone.0307364. eCollection 2024.
6
The relationship between health literacy and adherence to personal protective anti-COVID-19 measures in health workers and their relatives: A mixed methods design.医护人员及其亲属的健康素养与个人防护 COVID-19 措施依从性之间的关系:混合方法设计。
Medicine (Baltimore). 2024 Jun 14;103(24):e38505. doi: 10.1097/MD.0000000000038505.
7
Improve the satisfaction of medical staff on the use of home nursing mobile APP by using a hybrid multi-standard decision model.通过使用混合多标准决策模型提高医护人员对家庭护理移动应用程序使用的满意度。
BMC Nurs. 2024 May 9;23(1):302. doi: 10.1186/s12912-024-01918-9.
8
Quantifying holistic capacity response and healthcare resilience in tackling COVID-19: Assessment of country capacity by MCDM.量化整体应对能力和医疗保健弹性以应对 COVID-19:基于多准则决策的国家能力评估。
PLoS One. 2024 Apr 5;19(4):e0294625. doi: 10.1371/journal.pone.0294625. eCollection 2024.
9
COVID-19 pandemic fatigue among well-educated egyptian population: Cross-sectional study.COVID-19 大流行疲劳在受过良好教育的埃及人群中的表现:横断面研究。
Ann Afr Med. 2023 Oct-Dec;22(4):426-433. doi: 10.4103/aam.aam_126_22.
10
Evaluating COVID-19 infection prevention measures in Malaysia: A fuzzy DEMATEL approach.评估马来西亚的新冠肺炎感染预防措施:一种模糊DEMATEL方法。
Digit Health. 2023 Dec 6;9:20552076231211670. doi: 10.1177/20552076231211670. eCollection 2023 Jan-Dec.
Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.00597-2020. Print 2020 Apr.
4
COVID-19 and Italy: what next?COVID-19 和意大利:下一步如何?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
5
Can we contain the COVID-19 outbreak with the same measures as for SARS?我们能否用应对 SARS 的相同措施来控制 COVID-19 疫情?
Lancet Infect Dis. 2020 May;20(5):e102-e107. doi: 10.1016/S1473-3099(20)30129-8. Epub 2020 Mar 5.
6
Critical care crisis and some recommendations during the COVID-19 epidemic in China.中国新冠疫情期间的重症护理危机及一些建议。
Intensive Care Med. 2020 May;46(5):837-840. doi: 10.1007/s00134-020-05979-7. Epub 2020 Mar 2.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
9
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.中国武汉不明原因肺炎疫情:谜团与奇迹
J Med Virol. 2020 Apr;92(4):401-402. doi: 10.1002/jmv.25678. Epub 2020 Feb 12.
10
Barriers for implementation of successful change to prevent musculoskeletal disorders and how to systematically address them.成功实施改变以预防肌肉骨骼疾病的障碍,以及如何系统地解决这些障碍。
Appl Ergon. 2018 Nov;73:122-140. doi: 10.1016/j.apergo.2018.05.004. Epub 2018 Jun 29.